{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:58:46Z","timestamp":1747155526641,"version":"3.40.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.arcped.2024.02.004","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T05:25:19Z","timestamp":1713417919000},"page":"315-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-term azithromycin use is associated with QTc interval prolongation in children with cystic fibrosis"],"prefix":"10.1016","volume":"31","author":[{"given":"As\u0131m","family":"Enho\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazar","family":"Do\u011fu\u015f Kus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7693-0261","authenticated-orcid":false,"given":"Can Yilmaz","family":"Yozgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"Cak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Yazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Berk","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk","family":"Erenberk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilmaz","family":"Yozgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2024.02.004_bib0001","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.; Cystic Fibrosis Foundation, Pulmonary Therapies Committee","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1513\/AnnalsATS.201801-012OC","article-title":"Chronic azithromycin use in cystic fibrosis and risk of treatment-emergent respiratory pathogens","volume":"15","author":"Cogen","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arcped.2024.02.004_bib0004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3949\/ccjm.75.8.591","article-title":"Congenital long QT syndrome: considerations for primary care physicians","volume":"75","author":"Levine","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Eng J Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jhm.2448","article-title":"Baseline QTc and azithromycin evaluation","volume":"1","author":"Lee","year":"2016","journal-title":"J Hosp Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"Van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2024.02.004_bib0008","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.arcped.2024.02.004_bib0009","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2024.02.004_bib0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcf.2015.11.012","article-title":"An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis","volume":"15","author":"Lenehan","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2024.02.004_bib0011","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.arcped.2024.02.004_bib0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2004.07.019","article-title":"Acquired QT interval prolongation and hERG: implications for drug discovery and development","volume":"500","author":"Finlayson","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arcped.2024.02.004_bib0013","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2024.02.004_bib0014","first-page":"15","article-title":"Federal Drug Commission. FDA\/PhRMA task force to assess QT risk by pre-clinical markers","volume":"61","year":"1999","journal-title":"Pink Sheet"},{"key":"10.1016\/j.arcped.2024.02.004_bib0015","first-page":"121","article-title":"Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval","volume":"2","author":"Lannini","year":"2002","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.arcped.2024.02.004_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00787-006-0573-0","article-title":"The QT interval and psychotropic medications in children: recommendations for clinicians","volume":"16","author":"McNally","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.arcped.2024.02.004_bib0017","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.2012.6421","article-title":"Cardiovascular death risk linked to azithromycin use","volume":"307","author":"Kuehn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2024.02.004_bib0018","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9343(02)01455-9","article-title":"Prescription of QT Prolonging drugs in a cohort of about 5 million outpatients","volume":"2","author":"Curtis","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.arcped.2024.02.004_bib0019","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12012-014-9289-4","article-title":"Azithromycin can prolong QT interval and suppress ventricular contraction, but will not induce torsade de pointes","volume":"3","author":"Ohara","year":"2015","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.arcped.2024.02.004_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","article-title":"The hERG potassium channel and hERG screening for drug-induced torsades de pointes","volume":"119","author":"Hancox","year":"2008","journal-title":"Pharmacol Therapeut"},{"key":"10.1016\/j.arcped.2024.02.004_bib0021","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/S0735-1097(96)00377-4","article-title":"Cellular and ionic mechanism underlying erythromycin induced long QT intervals and torsade de pointes","volume":"28","author":"Antzelevitch","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arcped.2024.02.004_bib0022","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/eurheartj\/ehn452","article-title":"Changes of the corrected QT interval in healthy boys and girls over day and night","volume":"2","author":"Krasemann","year":"2009","journal-title":"Eur Heart J"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X24000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X24000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T19:22:19Z","timestamp":1719861739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X24000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0929693X24000605"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2024.02.004","relation":{},"ISSN":["0929-693X"],"issn-type":[{"type":"print","value":"0929-693X"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term azithromycin use is associated with QTc interval prolongation in children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2024.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}